Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patients with Fontan failure, will cardiac rehabilitation improve exertional tolerance (as measured by cardiopulmonary exercise testing), frailty, and self-reported quality of life metrics compared to usual care?


Clinical Trial Description

REHAB Fontan Failure is a a multi-center, non-blinded, randomized clinical trial evaluating the effect of cardiac rehabilitation compared to usual care on exercise tolerance among adults with Fontan failure. Eligible study subjects will be identified from clinical chart review and study informational fliers will be sent to Adult Congenital Heart Disease (ACHD) cardiologists at all centers. Fontan failure patients being evaluated for outpatient care at ACHD centers and meeting eligibility criteria will be enrolled and randomly assigned to either cardiac rehabilitation or usual clinical care. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06150950
Study type Interventional
Source Stanford University
Contact
Status Not yet recruiting
Phase N/A
Start date November 28, 2023
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT03119090 - Fontan Imaging Biomarkers (FIB) Study
Completed NCT05063903 - Exercise Capacity in Patients With Fontan Procedure
Not yet recruiting NCT04017494 - Validation of Cardiac Magnetic Resonance Sequences in Patients With Single Ventricles
Recruiting NCT04106479 - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Completed NCT03481985 - The Effect of Fontan Fenestration Closure on Hepatic Stiffness
Completed NCT03088345 - Early Use of Vasopressin in Post-Fontan Management Phase 2/Phase 3
Completed NCT03470428 - Clinical Characteristics and Associations of the "Good Fontan" Patient
Completed NCT04956952 - Enhanced External Counterpulsation in Patients With Fontan Circulation N/A
Completed NCT04785482 - The PaTHS Descriptive Correlational Longitudinal Study
Withdrawn NCT03997097 - Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease Phase 3
Completed NCT05118152 - Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle
Recruiting NCT05262907 - Ventripoint Single Ventricle Study N/A
Withdrawn NCT01149603 - The Destination Therapy Evaluation for Failing Fontan Study N/A
Recruiting NCT04467671 - Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts Phase 2
Completed NCT03339466 - Inspiratory Muscle Therapy in Subjects With Fontan Circulations N/A
Completed NCT05011565 - Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Active, not recruiting NCT03263312 - Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient N/A
Recruiting NCT05034354 - Virtual Remote Physiological Monitoring Program of Children With Heart Disease N/A
Completed NCT04613934 - Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease
Recruiting NCT04901975 - Fibrosis and the Fontan Phase 1/Phase 2